NCT05071833

Effects of Peppermint Oil in Cardiometabolic Outcomes

Effects of Oral Peppermint Supplementation on Cardiometabolic Parameters

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 36 (actual)
• Sponsor: University of Central Lancashire · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

Cardiovascular disease, type 2 diabetes mellitus and associated diseases combined are the leading health burden and cause of mortality worldwide; therefore, the necessity for an intervention is paramount. Dietary interventions to improve cardiometabolic health are highly sought after as they possess less risk than pharmacological drugs. Previous non-randomized interventions have shown that oral peppermint may be beneficial in improving cardiometabolic outcomes. However, to date, no research has explored this using a placebo randomized intervention. Therefore, the primary purpose of the proposed investigation is to test the ability of oral peppermint oil supplementation to improve cardiometabolic parameters in healthy individuals.

Conditions

• Cardiometabolic Syndrome

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Peppermint oil.	Peppermint oil.
OTHER	Placebo	Placebo

Timeline

• Start date: 2021-11-01
• Primary completion: 2022-08-15
• Completion: 2022-11-05
• First posted: 2021-10-08
• Last updated: 2023-03-31

Locations

1 site across 1 country: United Kingdom